Form 483

Similasan AG Form 483, 2026-04-27

FDA issued a Form 483 to Similasan AG on 2026-04-27 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Similasan AG · Jonen, Switzerland · Issued April 27, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Apr 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Matthew B Casale, Saleem A Akhtar

27 Apr 2026
21 CFR 211.160(b)(1)

Determination of conformance

Cited by Matthew B Casale, Saleem A Akhtar

27 Apr 2026
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Matthew B Casale, Saleem A Akhtar

Inspected site

SASimilasan AGJonen, Switzerland

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere